SCHEMBL1735908

SCHEMBL1735908

O=S(=O)(O)C(F)(F)C(F)C(F)(F)F.[NaH]

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL356425 0.97 ALDH1A1 (0.36) ALDH1A1L3MBTL1
SCHEMBL7708236 0.95 ALDH1A1 (0.35) ALDH1A1L3MBTL1
Iodide SCHEMBL7702837 0.95 ALDH1A1 (0.35) ALDH1A1L3MBTL1
SCHEMBL357234 0.95 ALDH1A1 (0.35) ALDH1A1L3MBTL1
SCHEMBL9055082 0.95 ALDH1A1 (0.35) ALDH1A1L3MBTL1
Nitrogen SCHEMBL8669309 0.92 ALDH1A1 (0.33) ALDH1A1L3MBTL1
SCHEMBL30400091 0.86 ALDH1A1 (0.39) ALDH1A1L3MBTL1
SCHEMBL4450974 0.77 ALDH1A1 (0.33) ALDH1A1L3MBTL1
SCHEMBL1868907 0.77 CES1 (0.33)
SCHEMBL7787757 0.75 PTPN1 (0.34) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8027096-A None JP disclosed
US-20140286849-A1 Mixtures of Ammonia and Ionic Liquids E. I. DU PONT DE NEMOURS AND COMPANY (US) 2014-09-25 US disclosed
US-8715521-B2 Absorption cycle utilizing ionic liquid as working fluid E I DU PONT DE NEMOURS AND COMPANY (US) 2014-05-06 US disclosed
US-8707720-B2 Hybrid vapor compression-absorption cycle E I DU PONT DE NEMOURS AND COMPANY (US) 2014-04-29 US disclosed
US-8628644-B2 Utilizing ionic liquids for hydrofluorocarbon separation E I DU PONT NEMOURS AND COMPANY (US) 2014-01-14 US disclosed
US-8568608-B2 Vapor compression cycle utilizing ionic liquid as compressor lubricant E I DU PONT DE NEMOURS AND COMPANY (US) 2013-10-29 US disclosed
US-20130231448-A1 PROCESS FOR SEPARATION OF TETRAFLUOROETHYLENE FROM CARBON DIOXIDE USING IONIC LIQUIDS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-09-05 US disclosed
US-8313558-B2 Process for separation of tetrafluoroethylene from carbon dioxide using ionic liquids E I DU PONT DE NEMOURS AND COMPANY (US) 2012-11-20 US disclosed
EP-2129737-B1 HEAT TRANSFER SYSTEMS USING MIXTURES OF POLYOLS AND IONIC LIQUIDS DU PONT (US) 2012-10-17 EP disclosed
EP-1954680-B1 IONIC LIQUIDS DU PONT (US) 2012-05-23 EP disclosed
US-20070100181-A1 Olefin isomerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US disclosed
US-20070100193-A1 Olefin polymerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US disclosed
US-20070066854-A1 Preparation of polytrimethylene ether glycol and copolymers thereof THE CHEMOURS COMPANY FC, LLC 2007-03-22 US disclosed
US-20070066852-A1 Preparation of poly(tetramethylene) glycol THE CHEMOURS COMPANY FC, LLC 2007-03-22 US disclosed
US-20070066822-A1 Ionic liquids THE CHEMOURS COMPANY FC, LLC 2007-03-22 US disclosed
US-20070066853-A1 Preparation of poly(tetramethylene) glycol E. I. DU PONT DE NEMOURS AND COMPANY 2007-03-22 US disclosed
US-20070066834-A1 Ionic liquids E. I. DU PONT DE NEMOURS AND COMPANY 2007-03-22 US disclosed
US-20070019708-A1 Hybrid vapor compression-absorption cycle E. I. DU PONT DE NEMOURS AND COMPANY 2007-01-25 US disclosed
US-20060197053-A1 Absorption cycle utilizing ionic liquid as working fluid E. I. DU PONT DE NEMOURS AND COMPANY 2006-09-07 US disclosed
JP-H0827096-A LITHIUM ORGANIC SULFONATE ASAHI CHEM IND CO LTD 1996-01-30 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066853-A1 Preparation of poly(tetramethylene) glycol PARG, PUF60, TPR ALDH1A1 2896/4885L3MBTL1 2316/4885
US-20070066834-A1 Ionic liquids NUP205, PML, AQP4 ALDH1A1 3482/4885L3MBTL1 3533/4885
US-20130231448-A1 PROCESS FOR SEPARATION OF TETRAFLUOROETHYLENE FROM CARBON DIOXIDE USING IONIC LIQUIDS CNOT9, CA9, TAF9 ALDH1A1 4650/4885L3MBTL1 768/4885
US-20070066854-A1 Preparation of polytrimethylene ether glycol and copolymers thereof PARG, PTGES3, PGD ALDH1A1 840/4885L3MBTL1 3248/4885
US-20070100181-A1 Olefin isomerization OSBP, OXER1, ALOX12 ALDH1A1 685/4885L3MBTL1 1110/4885
US-20070066822-A1 Ionic liquids AFF2, AFF1, ZYX ALDH1A1 3728/4885L3MBTL1 857/4885
US-20070066852-A1 Preparation of poly(tetramethylene) glycol PARG, PUF60, TPR ALDH1A1 2896/4885L3MBTL1 2316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.